Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics.
about
Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.A missing link between RON expression and oncological outcomes in resected left-sided pancreatic cancer.RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.E47 Governs the MYC-CDKN1B/p27KIP1-RB Network to Growth Arrest PDA Cells Independent of CDKN2A/p16INK4A and Wild-Type p53.Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis
P2860
Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of RON protei ...... for biology and therapeutics.
@en
Characterization of RON protei ...... for biology and therapeutics.
@nl
type
label
Characterization of RON protei ...... for biology and therapeutics.
@en
Characterization of RON protei ...... for biology and therapeutics.
@nl
prefLabel
Characterization of RON protei ...... for biology and therapeutics.
@en
Characterization of RON protei ...... for biology and therapeutics.
@nl
P2093
P2860
P356
P1433
P1476
Characterization of RON protei ...... for biology and therapeutics.
@en
P2093
Andrew M Lowy
Christina Esdar
Dawn Jaquish
Evangeline Mose
Haleigh Howard
Jaclyn Miyamoto
Jan Eickhoff
Jeffery Chakedis
Michele Babicky
Oliver Schadt
P2860
P304
45959-45975
P356
10.18632/ONCOTARGET.10009
P407
P577
2016-06-14T00:00:00Z